High urinary phosphate levels may worsen kidney disease by causing inflammation and cyst growth.
High Urinary Phosphate Induces TLR4-mediated Inflammation and Cystogenesis in Polycystic Kidney Disease
This study is looking at how too much phosphate in urine might make autosomal dominant polycystic kidney disease (ADPKD) worse, and it aims to find out if certain dietary changes or treatments could help manage the condition better.
Quick facts
| Grant type | R15 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Michigan Technological University NIH-funded |
| Lab location | 1 site (Houghton, United States) |
| Project ID | NIH-10730615 on NIH RePORTER |
What this research studies
This research investigates how high levels of urinary phosphate contribute to the progression of autosomal dominant polycystic kidney disease (ADPKD), a genetic condition that leads to kidney cyst formation and dysfunction. The study will explore the role of toll-like receptor 4 (TLR4) in mediating inflammation and cyst growth triggered by elevated phosphate levels. By examining the effects of dietary phosphate on kidney health and the potential therapeutic role of resolvins, the research aims to identify new strategies for managing ADPKD.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with autosomal dominant polycystic kidney disease (ADPKD) who may be affected by dietary phosphate intake.
Not a fit: Patients without a diagnosis of ADPKD or those with other unrelated kidney conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new dietary recommendations and treatments that slow the progression of kidney disease in affected patients.
How similar studies have performed: Previous studies have shown that dietary phosphate restriction can slow disease progression in animal models of ADPKD, suggesting that this approach may be promising.
Where this research is happening
Houghton, United States
- Michigan Technological University — Houghton, United States (Active)
Researchers
- Principal investigator: Zhang, Yan — Michigan Technological University
- Study coordinator: Zhang, Yan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.